The company, a division of BGI Group, sold 40.1 million shares at RMB 13.64 per share for a total of RMB 547 million ($80.6 million) in the offering.
NGeneBio is moving ahead with plans to have the test cleared for diagnostic use in Korea, while envisioning a 2019 submission to the US FDA.
BGI won't be selling the gene-edited miniaturized pigs it developed, according to Technology Review.
The partners will explore the possibility of building a sequencing hub at the university for conducting local population cohort studies and diagnostic testing.
Later this year, BGI Europe and its partner Genome Diagnostics Nijmegen plan to offer complete diagnostic exome sequencing including clinical interpretation.
By combining in vivo and in vitro proximity ligation technologies, highly accurate and contiguous genomes can help accelerate more traditional, genetic-marker based crop breeding.
The potential cross-Pacific partnership could help the Seattle-based research institute discover and define cell types in the human brain.
BGI showed that its BGISEQ-500 can sequence a human genome, and that compared to the HiSeq 2500 it is comparable for SNP calling but worse for indels.
International research teams collaborated to create five fully functioning synthetic yeast chromosomes, taking them one step closer to a whole synthetic genome.
Gene drives might run into biological resistance, the Economist reports.
Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.
Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.
In Science this week: full CRISPR locus integration complex structure, and more.